ZA200606554B - Pharmaceutical composition for oral application and method for preparing thereof - Google Patents

Pharmaceutical composition for oral application and method for preparing thereof

Info

Publication number
ZA200606554B
ZA200606554B ZA200606554A ZA200606554A ZA200606554B ZA 200606554 B ZA200606554 B ZA 200606554B ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 A ZA200606554 A ZA 200606554A ZA 200606554 B ZA200606554 B ZA 200606554B
Authority
ZA
South Africa
Prior art keywords
preparing
pharmaceutical composition
oral application
composition
oral
Prior art date
Application number
ZA200606554A
Other languages
English (en)
Inventor
Mattern Claudia
Pieper Wilfried
Original Assignee
Cum Pharma Consulting Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cum Pharma Consulting Anstalt filed Critical Cum Pharma Consulting Anstalt
Publication of ZA200606554B publication Critical patent/ZA200606554B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
ZA200606554A 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof ZA200606554B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04003906A EP1566173B1 (en) 2004-02-20 2004-02-20 Pharmaceutical composition for oral application and method for preparing thereof

Publications (1)

Publication Number Publication Date
ZA200606554B true ZA200606554B (en) 2008-05-28

Family

ID=34707350

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200606554A ZA200606554B (en) 2004-02-20 2005-02-09 Pharmaceutical composition for oral application and method for preparing thereof

Country Status (16)

Country Link
US (1) US7767228B2 (da)
EP (2) EP1566173B1 (da)
JP (1) JP4800225B2 (da)
AT (1) ATE336230T1 (da)
AU (1) AU2005215108B2 (da)
BR (1) BRPI0507848A (da)
CA (1) CA2554640C (da)
DE (1) DE602004001969T2 (da)
DK (1) DK1566173T3 (da)
ES (1) ES2271714T3 (da)
NO (1) NO20064240L (da)
PT (1) PT1566173E (da)
RU (1) RU2342936C2 (da)
SI (1) SI1566173T1 (da)
WO (1) WO2005079759A2 (da)
ZA (1) ZA200606554B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2608505C (en) * 2005-05-18 2013-12-24 Da Volterra Colonic delivery of adsorbents
US8048413B2 (en) 2006-05-17 2011-11-01 Helene Huguet Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules
UY31410A1 (es) * 2007-10-30 2009-05-29 Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
JP2010106007A (ja) * 2008-08-14 2010-05-13 Sony Corp 薬剤徐放剤、吸着剤、機能性食品、マスク及び吸着シート
AU2009321822B2 (en) * 2008-12-05 2015-04-16 Bayer Intellectual Property Gmbh Extrudate having spicular active substances
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
RU2514056C2 (ru) * 2012-08-21 2014-04-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования Курская государственная сельскохозяйственная академия имени профессора И.И. Иванова Министерства сельского хозяйства Российской Федерации Способ инкапсуляции фенбендазола
JP6472341B2 (ja) * 2015-06-26 2019-02-20 株式会社トーヨー技術研究所 固形状の魚類用経口投与薬剤、当該薬剤を含む養魚用飼料、および当該薬剤を魚に投与する方法
EP4208157A1 (en) 2020-09-04 2023-07-12 Elanco Us Inc. Palatable formulations
WO2023032048A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤
WO2023032049A1 (ja) * 2021-08-31 2023-03-09 株式会社トーヨー技術研究所 水棲動物用経口投与薬剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1879601A (en) * 1926-03-13 1932-09-27 Merck & Co Inc Iodine composition
NL294490A (da) * 1962-06-25
US3709833A (en) * 1970-08-21 1973-01-09 Owens Illinois Inc Process for preparing high purity silicon oxide porous beads doped with small quantities of other oxides
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
SU1465052A1 (ru) * 1985-06-10 1989-03-15 Институт Зоологии Ан Казсср Способ профилактики и лечени гельминтозов животных
US5013716A (en) * 1988-10-28 1991-05-07 Warner-Lambert Company Unpleasant taste masking compositions and methods for preparing same
JPH05238930A (ja) * 1992-02-28 1993-09-17 Eisai Co Ltd 持続性薬剤
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US5827497A (en) * 1996-08-14 1998-10-27 Mayo Foundation For Medical Education And Research Charcoal-radionuclide agents for measurement of gastrointestinal transit
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
DE19726412A1 (de) * 1997-06-21 1998-12-24 Merck Patent Gmbh Implantatmaterial mit einer Träger-Wirkstoff-Kombination
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JP3834732B2 (ja) * 1998-08-05 2006-10-18 株式会社ロッテ チューインガム
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
EP1362583A1 (de) * 2002-05-15 2003-11-19 CUM Taste Masking AG Verfahren zur Geschmacksmaskierung von Substanzen durch Mikroverkapselung
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
EP2314171B1 (en) * 2002-08-13 2019-11-13 Intervet International BV Compositions and process for delivering an additive
CN100347889C (zh) * 2002-10-31 2007-11-07 松下电器产业株式会社 多孔电极及使用该电极的电化学元件

Also Published As

Publication number Publication date
ATE336230T1 (de) 2006-09-15
AU2005215108A1 (en) 2005-09-01
DE602004001969T2 (de) 2007-03-15
DK1566173T3 (da) 2006-12-27
CA2554640C (en) 2011-04-12
WO2005079759A3 (en) 2006-06-15
DE602004001969D1 (de) 2006-09-28
PT1566173E (pt) 2006-12-29
CA2554640A1 (en) 2005-09-01
BRPI0507848A (pt) 2007-07-10
WO2005079759A2 (en) 2005-09-01
EP1715850A2 (en) 2006-11-02
AU2005215108B2 (en) 2010-10-07
US7767228B2 (en) 2010-08-03
JP2007523108A (ja) 2007-08-16
NO20064240L (no) 2006-11-20
RU2006133543A (ru) 2008-04-10
EP1566173A1 (en) 2005-08-24
SI1566173T1 (sl) 2006-12-31
EP1566173B1 (en) 2006-08-16
ES2271714T3 (es) 2007-04-16
US20050186272A1 (en) 2005-08-25
RU2342936C2 (ru) 2009-01-10
JP4800225B2 (ja) 2011-10-26

Similar Documents

Publication Publication Date Title
ZA200606554B (en) Pharmaceutical composition for oral application and method for preparing thereof
MXPA04004464A (es) Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades.
EE200300373A (et) Meetod kamptotetsiini analoogide sünteesimiseks kasutatavate ühendite valmistamiseks ning kamptotetsiini analoogide terviksüntees
BR0308452A (pt) composições farmacêuticas e métodos de preparação de composição farmacêutica
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
IL182179A0 (en) ANALOGS OF ShK TOXIN AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
HK1076605A1 (en) Formulations
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
WO2007052123A3 (en) Pyrazine derivatives as sodium channel modulators for the treatment of pain
ATE521338T1 (de) Pharmazeutische formulierungen mit metformin und einem fibrat und herstellungsverfahren dafür
TW200716204A (en) Pharmaceutical composition
ES2328496T3 (es) Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos.
WO2004100865A3 (en) New benzimidazole derivatives
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2007129066A8 (en) 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
AU2003230189A1 (en) Oral controlled release pharmaceutical composition containing metaxalone as active agent
HK1077232A1 (en) Medicinal composition for mitigating blood lipid or lowering blood homocystein
WO2005120584A3 (en) Radiolabeled arylsulfonyl compounds and uses thereof
IL172758A0 (en) Pharmaceutical compositions containing balaglitazone and methods for the preparation thereof
SG161207A1 (en) Compositions comprising an epothilone and production methods
WO2007080117A3 (de) Schichtsilicatformulierung für eine kontrollierte wirkstofffreisetzung
GB2418855B (en) Use of ethyl lactate as an excipient for pharmaceutical compositions
HUP0204430A3 (en) Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
AU2003270202A1 (en) Pharmaceutical compositions increasing camp useful for the treatment of cancers
GB2405338B (en) Composition comprising antibodies for the prophylaxis of respiratory infections